From: Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer
Primer Name
Sequence (5’ to 3’)
PRKAR1B-AS1(For)
ATGACATGGGCAGACACAGA
PRKAR1B-AS1(Rev)
AGAGAGGTTCCGAATGCACA
C20rf91(For)
GGGAGGTTTGTGACTAGGCT
C20rf91(Rev)
TCGGAAGACAGCAAGAGTGT
GAPDH(For)
GGAGCGAGATCCCTCCAAAAT
GAPDH(Rev)
GGCTGTTGTCATACTTCTCATGG